Clinical Trial Update: Mirena Observational Program

View source ↗

Summary

Bayer-sponsored Mirena observational program has completed, evaluating its use for contraception and heavy menstrual bleeding, with investigations into endometr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Hyperplasia
• Menorrhagia

Drugs mentioned

• Mirena (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Bayer | Conditions: Contraception, Menorrhagia | Status: COMPLETED